Implanting the HeartMate 6 (total artificial heart).

Mechanical circulatory support Pulmonary artery hypertension Total artificial heart Ventricular assist device Yamaguchi syndrome

Journal

Multimedia manual of cardiothoracic surgery : MMCTS
ISSN: 1813-9175
Titre abrégé: Multimed Man Cardiothorac Surg
Pays: England
ID NLM: 101495626

Informations de publication

Date de publication:
02 03 2021
Historique:
entrez: 10 3 2021
pubmed: 11 3 2021
medline: 1 6 2021
Statut: epublish

Résumé

The HeartMate 3 is a ventricular assist device that supports the heart with a centrifugal continuous flow. It contains a fully levitated rotor to minimize hemolysis and was initially designed as an apical intrapericardial implant. It can be used as a bridge to a transplant, to recovery, or to destination therapy. After we excise the ventricles, we implant 2 HeartMate 3 devices as a total artificial heart (HeartMate 6). The patient was 35 years old when the devices were implanted and had been diagnosed with Yamaguchi syndrome (apical hypertrophic cardiomyopathy) at 13 years of age. Being listed for a transplant was not an option due to secondary pulmonary hypertension. Furthermore, the conventional method of apically implanting a left ventricular assist device was not possible due to the underlying pathology. A HeartMate 6 implant as a bridge to transplant therapy was planned. Additionally, a CardioMEMS HF System was implanted to monitor the pulmonary artery pressure. The video tutorial provides step-by-step instructions for implanting 2 HeartMate 3 devices as a total artificial heart.

Identifiants

pubmed: 33691041
doi: 10.1510/mmcts.2021.012
doi:

Types de publication

Case Reports Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author 2021. Published by MMCTS on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Erhan Urganci (E)

Department of Cardiac Surgery, Medical University of Vienna, Austria

Dominik Wiedemann (D)

Department of Cardiac Surgery, Medical University of Vienna, Austria

Julia Riebandt (J)

Department of Cardiac Surgery, Medical University of Vienna, Austria

Anne-Kristin Schaefer (AK)

Department of Cardiac Surgery, Medical University of Vienna, Austria

Stephan Hornykewycz (S)

Department of Anesthesia, Critical Care and Pain Medicine, Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria

Guenther Laufer (G)

Department of Cardiac Surgery, Medical University of Vienna, Austria

Daniel Zimpfer (D)

Department of Cardiac Surgery, Medical University of Vienna, Austria

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH